Abstract
Infectious diseases are the world’s second most significant cause of human death. Staphylococcus aureus is perhaps the human’s greatest concern because of its inherent virulence and its ability to cause a wide variety of life-threatening infections and its capability to adapt under various conditions. The drug resistance of S. aureus has gradually increased due to the adaptation of bacteria and the excessive use of antibiotics. There are many anti-staphylococcus drugs; however, they quickly lose their therapeutic value due to the resistance mechanisms developed by the bacteria. The major fundamental mechanisms of antimicrobial resistance are enzymatic degradation of antibacterial drugs, alteration of bacterial proteins that are antimicrobial targets and changes in membrane permeability to antibiotics. S. aureus develops resistance to beta-lactamase through the acquisition of a genomic island called staphylococcus cassette chromosome (SCC mec) which carries methicillin resistance determinant called mecA. Biofilm formation and quorum sensing of S. aureus have shown resistance to different antibiotics. Therefore, understanding the drug resistance of MRSA (methicillin-resistant Staphylococcus aureus) correctly and elucidating its drug resistance mechanism at the molecular level is of great importance for the treatment of S. aureus infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akanbi, O. E., Njom, H. K., Fri, J., Otigbu, A. C., & Clarke, A. M. (2017). Antimicrobial susceptibility of Staphylococcus aureus isolated from recreational waters and beach sand in Eastern cape province of south Africa. International Journal of Environmental Research and Public Health, 14(9), 1001. https://doi.org/10.3390/ijerph14091001
Anne S., & Reisman R. E. (1995). Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol. Feb;74(2), 167–70.
Archer, G. L., & Crossly, K. B. (1997). The Staphylococci in human disease. Elsevier.
Aziz, Z. S., & Hassan, M. A. (2019). Phenotypic and molecular study of mecA gene in MRSA isolated from clinical isolates in Misan Province. Indian Journal of Public Health Research and Development, 10, 553–558. https://doi.org/10.5958/0976-5506.2019.00350.4
Bitrus, A. A., Peter, O. M., Abbas, M. A., & Goni, M. D. (2018). Staphylococcus aureus: A review of antimicrobial resistance mechanisms. Research Reviews, 4(2), 43–54.
Carboneau, C., Benge, E., Jaco, M. T., & Robinson, M. (2010). A lean six sigma team increases hand hygiene compliance and reduces hospital-acquired MRSA infections by 51%. Journal for Healthcare Quality, 32, 61–70.
Cazares-Domínguez, V., Cruz-Cordova, A., Ochoa, S. A., Escalona, G., Arellano-Galindo, J., & Rodríguez-Leviz. (2015). Vancomycin tolerant, methicillin-resistant Staphylococcus aureus the effects of vancomycin on cell wall thickening. PLoS One, 10(3), e0118791. https://doi.org/10.1371/journal.pone.0118791
Chambers, H. F. (1997). Methicillin resistance in Staphylococci molecular and biochemical basis and clinical implications. Clinical Microbiology Reviews, 10(4), 781–791.
Chen, Y., Liu, T., Wang, K., Hou, C., Cai, S., Huang, Y., Du, Z., Huang, H., Kong, J., & Chen, Y. (2016). Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro. PLoS One, 11, e153468. https://doi.org/10.1371/journal.pone.0153468
Cluff, L. E., & Reynolds, R. J. (1965). Management of Staphylococcal infections. The American Journal of Medicine, 39, 812–825.
Damon, H. A., Soussy, C. J., & Courvalin, P. (1998). Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 42(10), 2590–2594.
Dever, L. A., & Dermody, T. S. (1991). Mechanisms of bacterial resistance to antibiotics. Archives of Internal Medicine, 151(5), 886–895. https://doi.org/10.1001/archinte.1991.00400050040010
Donlan, R. M. (2001). Biofilm formation: A clinically relevant microbiological process. Clinical Infectious Diseases, 33, 1387–1392. https://doi.org/10.1086/322972
Donlan, R. M. (2002). Microbial life on surfaces. Emerge Infectious Diseases, 8(9), 881–890. https://doi.org/10.3201/eid0809.020063
Fiebelkorn, K. R., Crawford, S. A., McElmeel, M. L., & Jorgensen, J. H. (2003). Practical disc diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative Staphylococci. Journal of Clinical Microbiology, 41, 4740–4744.
Fishovitz, J., Hermoso, J. A., Chan, M., & Mobashery, S. (2014). Penicillin- binding protein 2a of methicillin-resistant Staphylococcus aureus. IUBMB Life, 66(8), 572–577. https://doi.org/10.1002/iub.1289
Foster, T. J. (2017). Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiology Reviews, 41, 430–449.
Francolini, I., & Donelli, G. (2010). Prevention and control of biofilm-based medical-device-related infections. FEMS Immunology and Medical Microbiology, 59(3), 227–238. https://doi.org/10.1111/j.1574-695X.2010.00665x
Guo, Y., Song, G., Sun, M., & Wang, J. (2020). Prevalence and therapies of antibiotic resistance in Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology, 10, 107. https://doi.org/10.3389/fcimb.2020.00107
Gursoy, N. C., Ersoy, Y., Gunal, S., & Kuzucu, C. (2009). Antibiotic resistance in Staphylococcus aureus strains isolated from blood cultures. Ankem Dergisi, 23(1), 26–29.
Harris, L. G., Foster, S. J., & Richards, R. G. (2002). An Introduction to staphylococcus aureus and techniques for identification and quantifying Staphylococcus aureus adhesins about adhesion to biomaterials: Review. European Cells & Materials, 4, 4. https://doi.org/10.22203/eCM.v004a04
Hoiby, N., Ciofu, O., Johansen, H. K., Song, Z. J., Moser, C., Jensen, P. O., Molin, S., Givskov, M., & Tolker-Neilsen, T. (2011). The clinical impact of bacterial biofilms. International Journal of Oral Science, 3(2), 55–65. https://doi.org/10.4248/IJOS11026
Huijbers, P. M., Blaak, H., de Jong, M. C., Graat, E. A., Vandenbroucke-Grauls C. M., & de Roda Husman A. M. (2015). Role of the Environment in the Transmission of Antimicrobial Resistance to Humans: A Review. https://doi.org/10.1021/acs.est.5b02566
Ito, T., Katayama, Y., Asada, K., Mori, N., & Tsutsumimoto, K. (2001). Structural comparison of three types of Staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 45, 1323–1336. https://doi.org/10.1128/AAC.45.5.1323-1336.2001
Ito, T., Ma, X. X., Takeuchi, F., Okuma, K., Yuzawa, H., & Hiramatsu, K. (2004). Novel type V Staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrobial Agents and Chemotheraphy, 7, 2637–2651. https://doi.org/10.1128/AAC.48.7.2637-2651
Jessica, L., Alexander, R., Roy, J., & Carver, L. A. (2014). Staphylococcus aureus biofilms: Recent developments in biofilm dispersal. Frontiers in Cellular and Infection Microbiology, 2014, 178. https://doi.org/10.3389/fcimb.2014.00178
Ji, G., Beavis, R., & Novick, R. P. (1997). Bacterial interference caused by autoinducing peptide variants. Science, 276, 2027–2030. https://doi.org/10.1126/science.276.5321.2027
Kirby, W. M. (1944). Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science, 99, 452–453.
Kirmusaoglu, S. (2007). MRSA and MSSA: The mechanism of methicillin resistance and the influence of methicillin resistance on biofilm phenotype of Staphylococcus aureus. IntechOpen.
Kleerebezem, M., Quadri, L. E., & Kuipers, O. P. (1997). Quorum sensing by peptide pheromones and two- component signal-transduction signals in Gram-positive bacteria. Molecular Biology, 24(5), 895–904. https://doi.org/10.1046/j.1365-2958.1997.4251782.x
Le, K. Y. & Otto, M. (2015) Quorum-sensing regulation in staphylococci—an overview. Front. Microbiol. 6:1174. https://doi.org/10.3389/fmicb.2015.01174
Leski, T. A., & Tomasz, A. (2005). Role of penicillin binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-inking of evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. Journal of Bacteriology, 187(5), 1815–1824. https://doi.org/10.1128/JB.187.5.1815-1824
Levin, T. P., Suh, B., Axelrod, P., Truant, A. L., & Fekete, T. (2005). Potential clindamycin resistance in clindamycin-susceptible, erythromycin- resistant Staphylococcus aureus: report of a clinical failure. Antimicrobial Agents and Chemotherapy, 49, 1222–1224.
Li, M., Zou, P., Tyner, K., & Lee, S. (2017). Physiologically based pharmacokinetic (PBPK) modeling of pharmaceutical nanoparticles. The AAPS Journal, 19, 26–42. https://doi.org/10.1208/s12248-016-0010-3
Lowy, F. D. (1998). Staphylococcus aureus infections. The New England Journal of Medicine, 339, 520–532.
Lowy, F. D. (2003). Antimicrobial resistance: the example of staphylococcus aureus. The Journal of Clinical Investigation, 111, 1265–1273. https://doi.org/10.1172/JCI200318535
Malachowa, N., & DeLeo, F. R. (2010). Mobile genetic elements of staphylococcus aureus. Life Sciences, 67, 3057–3071. https://doi.org/10.1007/s00018-010-0389-4
Matsuoka, M., Inoue, M., Endou, K., & Nakajima, Y. (2003). Characteristic expression of three genes, msr(A), mph(C) and erm(Y), that confer resistance to macrolide antibiotics on Staphylococcus aureus. FEMS Microbiology Letters, 220, 287–293.
Mcclintock, B. (1951). Chromosome organisation and genic expression. Cold Spring Harbor Symposia on Quantitative Biology, 16, 13–47. https://doi.org/10.1101/SQB.1951.016.01.004
McNamara, P. J., Monroe, K. C., Khalili, S., & Proctor, R. A. (2000). Identification, cloning and initial characterization of rot, a locus encoding a regulator of virulence factor expression in Staphylococcus aureus. Journal of Bacteriology, 182, 3197–3202. https://doi.org/10.1128/JB.182.11.3197-3203
Miller, M. B. (2001). Quorum sensing in bacteria. Annual Review of Microbiology, 55(1), 165–199.
Moosdeen, F., & Williams, J. D. (1986). Antibiotic resistance in: epidemiology, mechanisms and therapeutic possibilities. Rev Infect Dis 8(Suppl 5): S555–S561.
Munita, J. M., Bayer, A. S., & Arias, C. A. (2015). Evolving resistance among Gram-positive pathogens. Clin Infect Dis, 61. https://doi.org/10.1093/cid/civ523
Nunes, L. D. C., Santos, K. R. N. D., Mondino, P. J. J., De Freire Bastos, M. D. C. D. F., & Giambiagi-Demarval, M. (1999). Detection of iles-2 gene encoding mupirocin resistance in methicillin- resistance Staphylococcus aureus by multiplex PCR. https://doi.org/10.1016/S0732-8893(99)00021-8
Peacock, S. J., & Paterson, G. K. (2015). Mechanism of MRSA resistance. Annual Review of Biochemistry, 84, 577–601. https://doi.org/10.1146/annurev-biochem-060614-034516
Peacock, S. J., & Peterson, G. K. (2015). Mechanisms of methicillin resistance in Staphylococcus aureus. Annual Review of Biochemistry, 2015, 34516. https://doi.org/10.1146/annurev-biochem-060614-034516
Piątkowska, E., Tkowski, J., & Mordarsk, A. P. (2012). The strongest resistance of staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. Cellular & Molecular Biology Letters, 17(4), 633–645. https://doi.org/10.2478/s11658-012-0034-3
Piriyaporn, C., Ito, T., Ma, X. X., Kondo, Y., Trakulsomboon, S., Tiensasitorn, C., Jamklang, M., Chavalit, T., Song, J.-H., & Hiramatsu, K. (2006). Staphylococcal Cassette Chromosome mec (SCC mec) typing of Methicillin- Resistant Staphylococcus aureus strains Isolated in 11 Asian countries: a proposal for a New Nomenclature for SCC mec Elements. Antimicrobial agents and Chemotherapy, March 2006, p. 1001–1012. https://doi.org/10.1128/AAC.50.3.1001-1012.2006.
Pillai, S. K., Sakoulas, G., Wennersten, C., Eliopoulos, G. M., Moellering, R. C. Jr, Ferraro, M. J., & Gold, H. S. (2002). Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis, 186(11), 1603–7. https://doi.org/10.1086/345368.
Plata, K., Rosato, A. E., & Wegrzyn, G. (2009). Staphylococcus aureus as an infective agent: overview of biochemistry and molecular genetics of its pathogenicity. Acta Biochemica Polnica, 56(4), 597–612.
Queck, S. Y., Jameson, L. M., Villaruz, A. E., Bach, T. H., Burhan, A., Khan, B. A., Sturdevant, D. E., Ricklefs, S. M., Li, M., & Ott, M. (2008). RNAIII- independent target gene control by the agr quorum-sensing system: Insight into the evolution of virulence regulation in Staphylococcus aureus. Molecular Cell, 32, 150–158.
Rabin, Z., Opoku-Temeng, D., Bonsu & Sintim. (2015). Future Med. Chem., 7(4), 493–512.
Ragbetli, C., Parlak, M., Bayram, Y., Guducuoglu, H., & Ceylan, N. (2016). Evaluation of antimicrobial resistance in Staphylococcus aureus isolates by years. Interdisciplinary Perspectives on Infectious Diseases, 2016, 9171395. https://doi.org/10.1155/2016/9171395
Ramage, G., Savile, S. P., Wickes, B. L., & Lopez, R. J. L. (2002). Inhibition of Candida albicans biofilm formation by farnesol, a quorum sensing molecule. Applied and Environmental Microbiology, 68, 5459–5463.
Rasigade, J. P., Dumitrescu, O., & Lina, G. (2014). New epidemiology of staphylococcus aureus infections. Clinical Microbiology and Infection, 20, 587–588.
Reffuveille, F., Josse, J., Valle, Q., Mongaret, C., & Gangloff, S. C. (2017). Staphylococcus aureus biofilms and their impact on the medical field. IntechOpen.
Reygaert, W. C. (2018). An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiology, 4(3), 482–501. https://doi.org/10.3934/microbiol.2018.3.482
Sasirekha, B., Usha, M. S., Amruta, J. A., Ankit, S., Brinda, N., & Divya, R. (2014). Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus. 3 Biotech, 4, 85–89. https://doi.org/10.1007/s13205-013-0133-5
Shahid, A., Rasool, M., Akhter, N., Aslam, B., Hassan, A., & Sana, S. (2019). Innovative strategies for the control of biofilm formation in clinical settings. IntechOpen.
Sharma, D., Misba, L., & Khan, A. U. (2019). Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrobial Resistance and Infection Control, 8, 76. https://doi.org/10.1186/s13756-019-0533-3
Singh, S., Kumar, S., & Indrajit. (2017). Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. The Open Microbiology Journal, 11, 53. https://doi.org/10.2174/1874285801711010053
Smith, P. F., & Wilkinson, B. J. (1981). Synthesis of methicillin resistant Staphylococcus aureus. Journal of Bacteriology, 148, 610–617.
Stark, L. (2013). Staphylococcus aureus-aspects of pathogenesis and molecular epidemiology. Elsevier.
Steven, Y. C. T., Joshua, S., Eichenberger, E., Thomas, L., & Vance, G. (2015). Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations and management. Clinical Microbiology Reviews, 28(3), 603–661. https://doi.org/10.1128/CMR.00134-14
Thammavongsa, V., Kim, H. K., Missiakas, D., & Schneewind, O. (2015). Staphylococcal manipulation of host immune responses. Nature Reviews. Microbiology, 13(9), 529–543.
Tipper, D. J., & Strominger, J. L. (1965). Mechanism of action of penicillins: A proposal based on their structural similarity to acyl-d-amyl-d-alanine. Proceedings of the National Academy of Sciences of the United States of America, 54, 1133–1141.
Tomasz, A., & De Lencastre, H. (1994). Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 38, 2590–2598.
Van Tilburg, B. E., Lewenza, S., & Reckseidler, Z. S. (2015). Current research approaches to target biofilm infections. Journal of Postdoctoral Research, 3(6), 36–49.
Vlaeminck, J., Raafat, D., Surmann, K., Timbermont, L., Normann, N., Sellman, B., Willem, J. B., & Wamel, M.-k. S. (2020). Exploring virulence factors and alternative therapies against Staphylococcus aureus. Toxins, 12(11), 721. https://doi.org/10.3390/toxins12110721
Walsh, C. T., & Timothy, A. W. (2016). Antibiotics: Challenges, mechanisms opportunities. ASM Press.
Wang, W., Lin, X., Jiang, T., Peng, Z., Xu, J., Yi, L., Li, F., Fanning, S., & Baloch, Z. (2018). Prevalence and Characterization of Staphylococcus aureus Cultured from Raw Milk Taken From Dairy Cows With Mastitis in Beijing, China. Front. Microbiol. https://doi.org/10.3389/fmicb.2018.01123
Wyke, A. W., Ward, J. B., & Hayes, M. V. (1982). Synthesis of peptidoglycan in vivo in methicillin-resistant Staphylococcus aureus. European Journal of Biochemistry, 127, 553–558.
Yarwood, J. M., Patrick, M., & Schlievert, P. M. (2003). Quorum sensing in Staphylococcus infections. The Clinical Investigator, 112(11), 1620–1625. https://doi.org/10.1172/JCI20442
Zhang, H. Z., Hackbarth, C. J., Chansky, K. M., & Chambers, H. F. (2001). A proteolytic transmembrane signalling pathway and resistance to β-lactams in Staphylococci. Science, 291, 1962–1965.
Zhao, X., Yu, Z., & Ding, T. (2020). Quorum sensing regulation of antimicrobial resistance in bacteria. Microorganisms, 8(3), 425. https://doi.org/10.3390/microrganisms8030425
Zhou, W., Shan, W., Ma, X., Chang, W., Zhou, X., Lu, H., & Dai, Y. (2012). Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China. BMC Microbiology, 12, 240.
Zoabi, M., Keness, Y., Titler, N., & Bisharat, N. (2011). Compliance of hospital staff with guidelines for the active surveillance of methicillin-resistance Staphylococcus aureus (MRSA) and its impact on rates of nosocomial MRSA bacteremia. The Israel Medical Association Journal, 2011(13), 740–744.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Musini, A., Kandula, P., Giri, A. (2021). Drug Resistance Mechanism in Staphylococcus aureus. In: Maddela, N.R., García, L.C. (eds) Innovations in Biotechnology for a Sustainable Future. Springer, Cham. https://doi.org/10.1007/978-3-030-80108-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-80108-3_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80107-6
Online ISBN: 978-3-030-80108-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)